74 related articles for article (PubMed ID: 10233353)
1. Intravenous iron (III) hydroxide-sucrose complex for anaemia in epidermolysis bullosa.
Atherton DJ; Cox I; Hann I
Br J Dermatol; 1999 Apr; 140(4):773. PubMed ID: 10233353
[No Abstract] [Full Text] [Related]
2. [The application of intravenous iron Venofer in postpartum anemia syndrome or "a non-life-saving replaceable transfusion"].
Chalmanov N
Akush Ginekol (Sofiia); 2000; 39 Suppl 2():21-3. PubMed ID: 11188010
[No Abstract] [Full Text] [Related]
3. Treatment of iron deficiency anaemia in pregnancy and postpartum with special focus on intravenous iron sucrose complex.
Breymann C
J Med Assoc Thai; 2005 Oct; 88 Suppl 2():S108-9. PubMed ID: 17718296
[No Abstract] [Full Text] [Related]
4. Intravenous iron in chronic kidney disease: haemoglobin change shortly after treatment of patients neither on dialysis nor on erythropoietin.
Tagboto S; Cropper L; Mostafa S; Turner J; Bailey G; Pugh-Clarke K
J Ren Care; 2008 Sep; 34(3):112-5. PubMed ID: 18786076
[TBL] [Abstract][Full Text] [Related]
5. Darbepoetin alfa and ferric gluconate ameliorate the anemia associated with recessive dystrophic epidermolysis bullosa.
Kuo DJ; Bruckner AL; Jeng MR
Pediatr Dermatol; 2006; 23(6):580-5. PubMed ID: 17156003
[TBL] [Abstract][Full Text] [Related]
6. Intravenous iron in a primary-care clinic.
Maslovsky I
Am J Hematol; 2005 Apr; 78(4):261-4. PubMed ID: 15795917
[TBL] [Abstract][Full Text] [Related]
7. Cost-minimization analysis favours intravenous ferric carboxymaltose over ferric sucrose or oral iron as preoperative treatment in patients with colon cancer and iron deficiency anaemia.
Calvet X; Gené E; ÀngelRuíz M; Figuerola A; Villoria A; Cucala M; Mearin F; Delgado S; Calleja JL
Technol Health Care; 2016; 24(1):111-20. PubMed ID: 26409561
[TBL] [Abstract][Full Text] [Related]
8. Prediction of response to iron sucrose in inflammatory bowel disease-associated anemia.
Gasche C; Waldhoer T; Feichtenschlager T; Male C; Mayer A; Mittermaier C; Petritsch W;
Am J Gastroenterol; 2001 Aug; 96(8):2382-7. PubMed ID: 11513178
[TBL] [Abstract][Full Text] [Related]
9. Parenteral iron therapy in obstetrics: 8 years experience with iron-sucrose complex.
Perewusnyk G; Huch R; Huch A; Breymann C
Br J Nutr; 2002 Jul; 88(1):3-10. PubMed ID: 12117422
[TBL] [Abstract][Full Text] [Related]
10. Addressing patient concerns about intravenous iron therapy.
Robbins KC
Nephrol Nurs J; 2003 Apr; 30(2):220-4, 258. PubMed ID: 12737000
[TBL] [Abstract][Full Text] [Related]
11. Intravenous iron sucrose in two pregnant women with inflammatory bowel disease and severe iron deficiency anemia.
Krafft A; Breymann C; Huch R; Huch A
Acta Obstet Gynecol Scand; 2000 Aug; 79(8):720-2. PubMed ID: 10949245
[No Abstract] [Full Text] [Related]
12. Iron hydroxide polymaltose: iatrogenic cause of persistent iron deficiency anaemia despite continuous oral iron therapy.
Mehta BC
J Assoc Physicians India; 2002 Feb; 50():279-80. PubMed ID: 12038667
[No Abstract] [Full Text] [Related]
13. Selective use of recombinant human erythropoietin in pregnant patients with severe anemia or nonresponsive to iron sucrose alone.
Krafft A; Bencaiova G; Breymann C
Fetal Diagn Ther; 2009; 25(2):239-45. PubMed ID: 19506383
[TBL] [Abstract][Full Text] [Related]
14. Persistent iron deficiency anemia.
Bichile SK; Kumar V
J Assoc Physicians India; 2002 Apr; 50():617-8. PubMed ID: 12164437
[No Abstract] [Full Text] [Related]
15. Effects of iron(II) salts and iron(III) complexes on trace element status in children with iron-deficiency anemia.
Sözmen EY; Kavakli K; Cetinkaya B; Akçay YD; Yilmaz D; Aydinok Y
Biol Trace Elem Res; 2003 Jul; 94(1):79-86. PubMed ID: 12907830
[TBL] [Abstract][Full Text] [Related]
16. Anaemia in the critically ill patient: monitoring of erythropoietin therapy.
Thomas C; Wiesner C; Melchior SW; Thüroff JW
BJU Int; 2006 Jun; 97(6):1161-4. PubMed ID: 16686704
[No Abstract] [Full Text] [Related]
17. Efficacy and safety of intravenous iron sucrose therapy in a group of children with iron deficiency anemia.
Pinsk V; Levy J; Moser A; Yerushalmi B; Kapelushnik J
Isr Med Assoc J; 2008 May; 10(5):335-8. PubMed ID: 18605353
[TBL] [Abstract][Full Text] [Related]
18. Are ferric compounds useful in treatment of iron deficiency anemia?
Arvas A; Gür E
Turk J Pediatr; 2000; 42(4):352-3. PubMed ID: 11196760
[TBL] [Abstract][Full Text] [Related]
19. Effect of recombinant human erythropoietin and intravenous iron on anemia and disease activity in rheumatoid arthritis.
Kaltwasser JP; Kessler U; Gottschalk R; Stucki G; Möller B
J Rheumatol; 2001 Nov; 28(11):2430-6. PubMed ID: 11708414
[TBL] [Abstract][Full Text] [Related]
20. Achieving optimal patient outcomes with intravenous iron.
Colfer M
Nephrol Nurs J; 2003 Aug; 30(4):449-53; quiz 454-5. PubMed ID: 14533524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
